Age, average ± standard error
|
59.54 ± 1.19
|
58.23 ± 0.75
|
0.379
|
Gender, n (%)
|
Male
|
41(57%)
|
48(35%)
|
0.003
|
BMI, average ± standard error
|
22.03 ± 0.37
|
23.81 ± 0.30
|
< 0.0001
|
Smoking history, n (%)
|
22(31%)
|
19(14%)
|
0.004
|
Alcohol history, n (%)
|
25(35%)
|
19(14%)
|
< 0.0001
|
Chronic disease, n (%)
|
Hypertension
|
9(13%)
|
37(27%)
|
0.015
|
Type II diabetes
|
13(18%)
|
15(11%)
|
0.158
|
CA199, average ± standard error
|
357.29 ± 42.28
|
/
| |
Jaundice
|
21(29%)
|
0
|
< 0.0001
|
Tumor size, average ± standard error
|
3.79 ± 0.19
|
/
| |
Primary cancer site, n (%)
| |
/
| |
Uncinate process
|
13(18%)
| | |
Head
|
29(40%)
| | |
Body
|
17(24%)
| | |
Tail
|
13(18%)
| | |
Surgery, n (%)
| |
/
| |
Pancreaticoduodenectomy
|
26(36%)
| | |
Distal pancreatectomy
|
11(15%)
| | |
Palliative intervention techniques
|
35(49%)
| | |
AJCC staging, n (%)
| |
/
| |
I
|
8(11%)
| | |
II
|
28(39%)
| | |
III
|
18(25%)
| | |
IV
|
18(25%)
| | |